Health Care Archives - Page 470 of 478

1 minute read

U.S. FDA Defers Decision On BeiGene’s Filing For Esophageal Carcinoma Due To Pending Inspection

July 14, 10:33 AM

The U.S. Food and Drug Administration (FDA) has deferred decision on the Biologics License Application (BLA) for BeiGene’s (NASDAQ: BGNE) tislelizumab as a second-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC).

BGNE

1 minute read

Clene’s CNM-Au8 Shows Decreased Mortality Amyotrophic Lateral Sclerosis Patients

By Vandana Singh

July 14, 9:34 AM

Clene Inc (NASDAQ:CLNN) reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8 compared to initially randomized…

CLNN

1 minute read

Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study

By Ragothaman Srinivasan

July 14, 9:31 AM

The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with chemotherapy for never smoker patients with advanced non-small cell lung cancer (N

LTRN

1 minute read

Regeneron-Sanofi’s Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years

By Vandana Singh

July 14, 6:18 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Phase 3 trial of Dupixent (dupilumab) in children aged 1 to 11 years…

REGN

1 minute read

Novavax Secures FDA Emergency Authorization For Adjuvanted Covid-19 Vaccine

By Ragothaman Srinivasan

July 13, 5:59 PM

The U.S. Food and Drug Administration (FDA) grants emergency use authorization (EUA) to Novavax’s (NASDAQ: NVAX) lead candidate Adjuvanted (NVX-CoV2373) COVID-19 Vaccine for individuals 18 years of age and over.

NVAX

2 minute read

Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst

By Dylan Wechsler

July 13, 5:13 PM

SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar

BNTX

1 minute read

ContraFect Shares Plummet After Data Safety Monitoring Board Stops Late-Stage Aureus Bacteremia Study

By Ragothaman Srinivasan

July 13, 4:42 PM

The Data Safety Monitoring Board (DSMB) has recommended that ContraFect’s (NASDAQ: CFRX) on going DISRUPT trial be stopped because the conditional power of the study was below the pre-specified threshold for futility.

CFRX

1 minute read

Target To Exclusively Offer Bobbie, A USDA Organic Infant Formula

By Phil Hall

July 13, 4:05 PM

Target Corporation (NYSE: TGT) will soon be offering Bobbie, a European-style USDA Organic infant formula made by the same-named San Francisco company, as an exclusive offering in its stores and e-commerce site.

TGT